<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> is a well-known inducing factor of <z:mp ids='MP_0003674'>oxidative stress</z:mp> through activation of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase </plain></SENT>
<SENT sid="1" pm="."><plain>In addition to its plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> lowering effect, insulin may also have <z:chebi fb="11" ids="22586">antioxidant</z:chebi> activity and was shown to downregulate <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase expression in vitro </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we show that a short-term (3-day) intravenous insulin infusion in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> induces normalization of both glycemia and <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of circulating monocyte p47(phox) subunit </plain></SENT>
</text></document>